BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12777983)

  • 1. Body site of cutaneous malignant melanoma--a study on patients with hereditary and multiple sporadic tumours.
    Gillgren P; Brattström G; Frisell J; Palmgren J; Ringborg U; Hansson J
    Melanoma Res; 2003 Jun; 13(3):279-86. PubMed ID: 12777983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple primary melanomas: an analysis of cancer registry data from Victoria and New South Wales.
    Giles G; Staples M; McCredie M; Coates M
    Melanoma Res; 1995 Dec; 5(6):433-8. PubMed ID: 8589618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanoma and nonmelanoma skin cancer in patients with multiple tumours--evidence for new syndromes in a population-based study.
    Nielsen K; Ingvar C; Måsbäck A; Westerdahl J; Borg A; Sandberg T; Jonsson N; Nagel J; Olsson H
    Br J Dermatol; 2004 Mar; 150(3):531-6. PubMed ID: 15030338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Next Melanoma in Patients With Familial and Sporadic Melanoma by Number of Previous Melanomas.
    Chen T; Fallah M; Försti A; Kharazmi E; Sundquist K; Hemminki K
    JAMA Dermatol; 2015 Jun; 151(6):607-15. PubMed ID: 25671687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new computerized methodology to analyse tumour site in relation to phenotypic traits and epidemiological characteristics of cutaneous malignant melanoma.
    Gillgren P; Brattström G; Djureen Mårtensson E; Frisell J; Palmgren J; Ringborg U; Hansson J
    Br J Dermatol; 2002 Jun; 146(6):1023-30. PubMed ID: 12072071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Problems in assessing multiple cutaneous melanoma. A review on the accuracy of a population based cancer registry.
    Måsbäck A; Andersson G; Olsson H
    Cancer Epidemiol; 2010 Jun; 34(3):262-6. PubMed ID: 20346747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and histologic characteristics of malignant melanoma in families with a germline mutation in CDKN2A.
    van der Rhee JI; Krijnen P; Gruis NA; de Snoo FA; Vasen HFA; Putter H; Kukutsch NA; Bergman W
    J Am Acad Dermatol; 2011 Aug; 65(2):281-288. PubMed ID: 21570156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant melanomas on head/neck and foot: differences in time and latitudinal trends in Norway.
    Juzeniene A; Micu E; Porojnicu AC; Moan J
    J Eur Acad Dermatol Venereol; 2012 Jul; 26(7):821-7. PubMed ID: 21707773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological characteristics of cutaneous malignant melanoma of the head and neck--a population-based study.
    Gillgren P; Månsson-Brahme E; Frisell J; Johansson H; Larsson O; Ringborg U
    Acta Oncol; 1999; 38(8):1069-74. PubMed ID: 10665765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous malignant melanoma in south Sweden 1965, 1975, and 1985. A histopathologic review.
    Måsbäck A; Westerdahl J; Ingvar C; Olsson H; Jonsson N
    Cancer; 1994 Mar; 73(6):1625-30. PubMed ID: 8156490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma.
    Hoersch B; Leiter U; Garbe C
    Br J Dermatol; 2006 Oct; 155(4):771-7. PubMed ID: 16965427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does relative melanoma distribution by body site 1960-2004 reflect changes in intermittent exposure and intentional tanning in the Swedish population?
    Dal H; Boldemann C; Lindelöf B
    Eur J Dermatol; 2007; 17(5):428-34. PubMed ID: 17673388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of malignant melanoma in central Europe: risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society.
    Garbe C; Orfanos CE
    Pigment Cell Res; 1992; Suppl 2():285-94. PubMed ID: 1409431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple primary (even in situ) melanomas in a patient pose significant risk to family members.
    Chen T; Hemminki K; Kharazmi E; Ji J; Sundquist K; Fallah M
    Eur J Cancer; 2014 Oct; 50(15):2659-67. PubMed ID: 25103454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age at diagnosis and transmission of invasive melanoma in 23 families with cutaneous malignant melanoma/dysplastic nevi.
    Goldstein AM; Fraser MC; Clark WH; Tucker MA
    J Natl Cancer Inst; 1994 Sep; 86(18):1385-90. PubMed ID: 8072031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and anatomic presentation of cutaneous malignant melanoma in central Canada during a 50-year period: 1956 to 2005.
    Pruthi DK; Guilfoyle R; Nugent Z; Wiseman MC; Demers AA
    J Am Acad Dermatol; 2009 Jul; 61(1):44-50. PubMed ID: 19395122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant melanoma incidence in Connecticut (United States): time trends and age-period-cohort modeling by anatomic site.
    Chen YT; Zheng T; Holford TR; Berwick M; Dubrow R
    Cancer Causes Control; 1994 Jul; 5(4):341-50. PubMed ID: 8080946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple primary melanoma.
    Conrad N; Leis P; Orengo I; Medrano EE; Hayes TG; Baer S; Rosen T
    Dermatol Surg; 1999 Jul; 25(7):576-81. PubMed ID: 10469118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of invasive cancers following cutaneous malignant melanoma.
    Levi F; La Vecchia C; Randimbison L; Te VC; Erler G
    Int J Cancer; 1997 Sep; 72(5):776-9. PubMed ID: 9311593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence trends and familial risks in invasive and in situ cutaneous melanoma by sun-exposed body sites.
    Hemminki K; Zhang H; Czene K
    Int J Cancer; 2003 May; 104(6):764-71. PubMed ID: 12640685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.